Metabolomic analysis has proven to be a useful tool in biomarker discovery and the
molecular classification of cancers. In order to find new biomarkers, and to better understand …

Simple Summary Bladder cancer (BC) is the fourth most common cancer among men and
the tenth most common cancer among women. Since the overall prognosis for BC has not …

Bladder cancer is the most common tumor in the urinary system, with approximately 420,000
new cases and 160,000 deaths per year. The European Organization for Research and …

Bladder cancer (BC) is a common urological malignancy with a high probability of death and
recurrence. Cystoscopy is used as a routine examination for diagnosis and following patient …

Bladder cancer (BC) is one of the most frequently diagnosed types of urinary cancer.
Despite advances in treatment methods, no specific biomarkers are currently in use …

Bladder cancer (BC) is frequent cancer affecting the urinary tract and is one of the most
prevalent malignancies worldwide. No biomarkers that can be used for effective monitoring …

In the present study, we developed and validated a fast, simple, and sensitive quantitative
method for the simultaneous determination of eleven nucleosides and deoxynucleosides …

Purpose Bladder cancer (BC) is the 10th most common form of cancer worldwide and the
2nd most common cancer of the urinary tract after prostate cancer, taking into account both …

Simple Summary Bladder cancer is evidently a challenge as far as its prognosis and
treatment are concerned. The investigation of potential biomarkers and therapeutic targets is …

Bladder cancer has a high incidence worldwide accompanies by high recurrent rate after
treatment. The emergence of primary or acquired chemotherapy resistance leads to poor …